Cassava Sciences
SAVA
#9051
Rank
S$0.14 B
Marketcap
S$3.04
Share price
12.26%
Change (1 day)
-16.33%
Change (1 year)

Earnings for Cassava Sciences (SAVA)

Earnings in 2025 (TTM): -S$0.15 Billion

According to Cassava Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$0.19 Billion a decrease over its 2023 earnings that were of -S$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cassava Sciences from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.15 Billion-19.08%
2024 -S$0.19 Billion34.28%
2023 -S$0.14 Billion32.41%
2022 -S$0.11 Billion143.46%
2021 -S$42.04 Million383.92%
2020 -S$8.69 Million36.96%
2019 -S$6.35 Million-25.56%
2018 -S$8.52 Million-44.25%
2017 -S$15.29 Million-20.11%
2016 -S$19.13 Million5.32%
2015 -S$18.17 Million14.23%
2014 -S$15.9 Million-139.64%
2013 S$40.1 M
2010 -S$17.53 Million102.87%
2009 -S$8.64 Million-177.52%
2008 S$11.14 M-14.32%
2007 S$13 M-1942.21%
2006 -S$0.71 Million
2004 -S$49.83 Million75.1%
2003 -S$28.46 Million
2001 -S$22.15 Million20.49%
2000 -S$18.38 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.19 Billion 31.98%๐Ÿ‡บ๐Ÿ‡ธ USA